US-based biopharmaceutical company Longevity Biomedical, Inc, which is focused on advancing new technologies across therapeutics, health monitoring and digital health solutions to increase human health span, and special purpose acquisition Company Denali Capital Acquisition Corp have entered into a definitive business combination agreement, the companies said.
Upon closing of the transaction pursuant to the BCA, the combined company will operate as Longevity Biomedical, Inc. and is expected to list on NASDAQ under the ticker symbol "LBIO."
Arthur J. Gallagher Acquires Viking Bond Service
Emmes Acquires Essex Management to Expand Biopharma Services
Penta Acquires Copperfield Agency to Expand Stakeholder Engagement Solutions
Leipurin to Sell and Lease Back Swedish Warehouse Property for SEK 25m
Conygar Investment Disposes of Haverfordwest Development Site for GBP 9.65m
Valeura Energy Acquires Assets in Offshore Gulf of Thailand
VM7 to Acquire ARCA Recycling from JanOne
OZ Lithium to Acquire Mina Laguna Santa Maria in Argentina
Standard Solar Acquires 21 MW Solar Project Portfolio to Expand Portfolio in Northeast
Steller Acquires Travel Mindset to Expand Offerings in Influencer Marketing Field
Exigent Acquires JPG Plumbing and ThermaServe to Expand in Southeast
Credent Wealth Management Welcomes Miller Private Wealth and TruNorth Financial to Firm
Irwin Naturals Acquires Ketamine Media to Expand Reach in Ketamine Therapy Market
StorageMart Acquires Storage Space to Expand into Carmel, Indiana